Imago BioSciences Appoints Wan-Jen Hong, M.D., as Chief Medical Officer

SOUTH SAN FRANCISCO, Calif. — June 3, 2021 –(BUSINESS WIRE)– Imago BioSciences, Inc. (“Imago”), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today announced the appointment of Wan-Jen Hong, M.D., as chief medical officer.

Read More

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *